
Guru Sonpavde/adventhealth.com
Jun 12, 2025, 08:47
Guru Sonpavde: Genitourinary Medical Oncology Highlights From ASCO Annual Conference 2025
Guru Sonpavde, GU Oncology and Phase I Clinical Trials Director, Chair of Bladder Cancer Research at AdventHealth Central Florida, shared a post on LinkedIn:
“ASCO25 GU (Genitourinary) cancer highlights – pleased to write this commentary in Doximity from Advent Health, Central Florida Cancer Institute, Orlando, Florida”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 12, 2025, 08:39
Jun 12, 2025, 07:54
Jun 12, 2025, 07:29
Jun 12, 2025, 07:25